The  	The  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
night  	night  	 NN	O
vision  	vision  	 NN	O
goggles  	goggles  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
retinocortical  	retinocortical  	 JJ	B-NP
bioelectrical  	bioelectrical  	 JJ	I-NP
activity  	activity  	 NN	I-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
improvement  	improvement  	 NN	O
by  	by  	 IN	O
food  	food  	 NN	B-NP
supplement  	supplement  	 NN	I-NP
To  	To  	 TO	O
investigate  	investigate  	 VB	O
the  	the  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
luminance  	luminance  	 JJ	B-NP
variations 	variations 	 NNS	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
the  	the  	 DT	O
oral  	oral  	 JJ	B-NP
administration  	administration  	 NN	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
food  	food  	 NN	I-NP
supplement 	supplement 	 NN	I-NP
,  	,  	 ,	O
on  	on  	 IN	O
the  	the  	 DT	O
visual  	visual  	 JJ	O
bioelectric  	bioelectric  	 JJ	B-NP
response  	response  	 NN	I-NP
while  	while  	 IN	O
using  	using  	 VBG	O
of  	of  	 IN	O
Night  	Night  	 NNP	B-NP
Vision  	Vision  	 NNP	I-NP
Goggles  	Goggles  	 NNP	I-NP
( 	( 	 -LRB-	O
NVG 	NVG 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Two  	Two  	 CD	O
trials  	trials  	 NNS	O
were  	were  	 VBD	O
performed 	performed 	 VBN	O
,  	,  	 ,	O
both  	both  	 DT	O
enrolling  	enrolling  	 JJ	O
healthy  	healthy  	 JJ	O
male  	male  	 JJ	O
aircrew  	aircrew  	 JJ	O
members  	members  	 NNS	O
wearing  	wearing  	 VBG	B-NP
NVG 	NVG 	 NNP	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
recording  	recording  	 VBG	O
Visual  	Visual  	 NNP	B-NP
Evoked  	Evoked  	 NNP	I-NP
Potentials  	Potentials  	 NNP	I-NP
( 	( 	 -LRB-	O
VEPs 	VEPs 	 NNP	B-NP
)  	)  	 -RRB-	O
from  	from  	 IN	O
scalp  	scalp  	 JJ	O
electrodes 	electrodes 	 NNS	O
.  	.  	 .	O
Both  	Both  	 DT	O
foveal  	foveal  	 NN	B-NP
and  	and  	 CC	O
parafoveal  	parafoveal  	 JJ	B-NP
response  	response  	 NN	I-NP
were  	were  	 VBD	O
evaluated 	evaluated 	 VBN	O
.  	.  	 .	O
Latency  	Latency  	 NNP	B-NP
and  	and  	 CC	O
amplitude 	amplitude 	 NN	B-NP
,  	,  	 ,	O
P100  	P100  	 CD	B-NP
peak 	peak 	 NN	I-NP
,  	,  	 ,	O
were  	were  	 VBD	O
measured 	measured 	 VBN	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
set  	set  	 NN	O
of  	of  	 IN	O
measurements 	measurements 	 NNS	B-NP
,  	,  	 ,	O
VEPs  	VEPs  	 JJ	B-NP
parameters  	parameters  	 NNS	I-NP
were  	were  	 VBD	O
recorded  	recorded  	 VBN	O
during  	during  	 IN	O
unaided  	unaided  	 JJ	O
photopic  	photopic  	 JJ	B-NP
conditions  	conditions  	 NNS	I-NP
and  	and  	 CC	O
mesopic  	mesopic  	 JJ	B-NP
conditions  	conditions  	 NNS	I-NP
while  	while  	 IN	O
using  	using  	 VBG	O
3rd  	3rd  	 CD	B-NP
generation  	generation  	 NN	I-NP
plus  	plus  	 CC	O
NVG  	NVG  	 NNP	B-NP
( 	( 	 -LRB-	O
ANVIS  	ANVIS  	 NNP	B-NP
9 	9 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
second  	second  	 JJ	O
set  	set  	 NN	O
of  	of  	 IN	O
experiments 	experiments 	 NNS	O
,  	,  	 ,	O
after  	after  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
basal  	basal  	 JJ	B-NP
electrophysiological  	electrophysiological  	 JJ	I-NP
investigation  	investigation  	 NN	I-NP
during  	during  	 IN	O
mesopic  	mesopic  	 JJ	B-NP
conditions  	conditions  	 NNS	I-NP
using  	using  	 VBG	O
NVG 	NVG 	 NNP	B-NP
,  	,  	 ,	O
patients  	patients  	 NNS	O
started  	started  	 VBD	O
a  	a  	 DT	O
45  	45  	 CD	O
days  	days  	 NNS	O
oral  	oral  	 JJ	B-NP
treatment 	treatment 	 NN	I-NP
,  	,  	 ,	O
during  	during  	 IN	O
which  	which  	 WDT	O
they  	they  	 PRP	O
took  	took  	 VBD	O
3  	3  	 CD	O
tablets  	tablets  	 NNS	O
per  	per  	 IN	O
day  	day  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
food  	food  	 NN	B-NP
supplement 	supplement 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
tablets  	tablets  	 NNS	O
contained  	contained  	 VBD	O
a  	a  	 DT	O
mix  	mix  	 NN	O
of  	of  	 IN	O
anthocyanosides 	anthocyanosides 	 NN	B-NP
,  	,  	 ,	O
procyanidolic  	procyanidolic  	 JJ	B-NP
oligomers 	oligomers 	 NN	I-NP
,  	,  	 ,	O
lutein  	lutein  	 NN	B-NP
and  	and  	 CC	O
vitamins  	vitamins  	 JJ	O
A  	A  	 NN	O
and  	and  	 CC	O
E.  	E.  	 NNP	O
At  	At  	 IN	O
the  	the  	 DT	O
end  	end  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
treatment 	treatment 	 NN	O
,  	,  	 ,	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
tested  	tested  	 VBN	O
again  	again  	 RB	O
by  	by  	 IN	O
pattern-reversal  	pattern-reversal  	 NNP	B-NP
VEP  	VEP  	 NNP	I-NP
investigation  	investigation  	 NN	I-NP
during  	during  	 IN	O
aided  	aided  	 JJ	O
vision  	vision  	 NN	B-NP
condition  	condition  	 NN	I-NP
( 	( 	 -LRB-	O
wearing  	wearing  	 VBG	B-NP
NVG 	NVG 	 NNP	I-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
a  	a  	 DT	O
mesopic  	mesopic  	 JJ	B-NP
environment 	environment 	 NN	I-NP
.  	.  	 .	O
VEPs  	VEPs  	 JJ	B-NP
parameters 	parameters 	 NNS	I-NP
,  	,  	 ,	O
statistically  	statistically  	 RB	O
evaluated  	evaluated  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
two  	two  	 CD	O
tailed  	tailed  	 NNS	O
paired  	paired  	 VBN	B-NP
t-test 	t-test 	 JJ	I-NP
,  	,  	 ,	O
showed  	showed  	 VBD	O
that  	that  	 DT	O
latency  	latency  	 NN	B-NP
and  	and  	 CC	O
amplitude  	amplitude  	 NNS	B-NP
were  	were  	 VBD	O
respectively  	respectively  	 RB	O
increased  	increased  	 VBN	O
( 	( 	 -LRB-	O
p  	p  	 FW	O
< 	< 	 SYM	O
0.001  	0.001  	 FW	O
and  	and  	 CC	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.01  	0.01  	 CD	O
for  	for  	 IN	O
15 	15 	 CD	O
'  	'  	 ''	O
and  	and  	 CC	O
60 	60 	 NNP	O
'  	'  	 POS	O
minutes  	minutes  	 NNS	O
of  	of  	 IN	O
arc 	arc 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
decreased  	decreased  	 VBD	O
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
when  	when  	 WRB	O
measured  	measured  	 VBN	O
using  	using  	 VBG	O
NVG  	NVG  	 NNP	B-NP
with  	with  	 IN	O
respect  	respect  	 NN	O
to  	to  	 TO	O
unaided  	unaided  	 VB	O
basal  	basal  	 JJ	B-NP
conditions 	conditions 	 NNS	I-NP
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
VEP  	VEP  	 NNP	B-NP
response  	response  	 NN	I-NP
in  	in  	 IN	O
NVG  	NVG  	 NNP	B-NP
aided  	aided  	 VBD	I-NP
vision  	vision  	 NN	I-NP
was  	was  	 VBD	O
positively  	positively  	 RB	O
affected  	affected  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
oral  	oral  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
food  	food  	 NN	B-NP
supplement 	supplement 	 NN	I-NP
,  	,  	 ,	O
showing  	showing  	 VBG	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
decrease  	decrease  	 NN	O
of  	of  	 IN	O
latency  	latency  	 NN	B-NP
and  	and  	 CC	O
increase  	increase  	 NN	O
of  	of  	 IN	O
amplitude 	amplitude 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
NVG  	NVG  	 NNP	B-NP
impairs  	impairs  	 VBD	O
the  	the  	 DT	O
VEP  	VEP  	 NNP	B-NP
response 	response 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
such  	such  	 JJ	O
effect  	effect  	 NN	O
is  	is  	 VBZ	O
effectively  	effectively  	 RB	O
counteracted  	counteracted  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
oral  	oral  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
food  	food  	 NN	B-NP
supplement  	supplement  	 NN	I-NP
containing  	containing  	 VBG	O
a  	a  	 DT	O
combination  	combination  	 NN	O
of  	of  	 IN	O
sight  	sight  	 NN	O
improving  	improving  	 VBG	O
molecules  	molecules  	 NNS	O
that  	that  	 WDT	O
might  	might  	 MD	O
enhance  	enhance  	 VB	O
foveal  	foveal  	 JJ	B-NP
selectivity 	selectivity 	 NN	I-NP
,  	,  	 ,	O
central  	central  	 JJ	O
photoreceptors  	photoreceptors  	 JJ	B-NP
sensitivity  	sensitivity  	 NN	I-NP
and  	and  	 CC	O
magnocellular  	magnocellular  	 JJ	B-NP
fibers  	fibers  	 NNS	I-NP
effectiveness 	effectiveness 	 NN	O
.  	.  	 .	O
